SpeciCare is Biotechnology in United States that focus on cutting-edge therapies business. Founded in 2015. They cover business area such as developer, clinical solution, cancer patient, personalized therapy, store, tumor tissue, precision treatment option, physician, previously inaccessible innovative testing, clinical trial, cut-edge therapy, patient outcome, quality, life.
2015
( 9 years old in 2024 )
Cutting-edge Therapies
-
999 Chestnut Street Southeast
Suite 20
Gainesville, GA 30501
United States
Private
developerclinical solutioncancer patientpersonalized therapystoretumor tissueprecision treatment optionphysicianpreviously inaccessible innovative testingclinical trialcut-edge therapypatient outcomequalitylife
* We use standard office opening hours in near SpeciCare's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SpeciCare is Biotechnology business from United States that founded in 2015 (9 years old in 2024), SpeciCare business is focusing on Cutting-edge Therapies.
SpeciCare headquarter office and corporate office address is located in 999 Chestnut Street Southeast Suite 20 Gainesville, GA 30501 United States.
SpeciCare was founded in United States.
In 2024, SpeciCare is currently focus on cutting-edge therapies sector.
Above is snippet of Google Trends for "cutting-edge therapies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SpeciCare, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
